Clinical Trial

Delta GREENS Food is Medicine Intervention

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Mississippi is a place deeply rooted in cultural values, yet also a place where generations of communities have experienced persistent health challenges intertwined with poverty. This project focuses on Bolivar, Washington, and Sunflower, contiguous counties in the Delta that are designated as health disparity populations. Over 65% of the 100,000 residents are Black/African American and \~30% live at or below the poverty level. Obesity rates are high and the rate of diabetes is almost double the national average. Tufts University received a grant from the National Institute of Minority Health and Health Disparities to develop, test, and evaluate a Food is Medicine program in Mississippi. The Delta GREENS Food is Medicine (FIM) Project, is a collaborative project in Bolivar, Washington, and Sunflower counties in Mississippi. The intervention involves regularly distributed fruit and vegetable produce boxes as well as nutrition education materials to the intervention group. The control group will receive produce boxes later, after they complete study activities. The project's primary goal is to improve health outcomes by creating a FIM intervention. The Delta GREENS FIM Project aims to become a model for promoting nutrition security and management of chronic conditions in varied communities nationwide.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-04-08; most recent amendment 2026-04-09.
Status change: Recruiting → Active, Not Recruiting 2026-04-09
Status change: Not Yet Recruiting → Recruiting 2024-05-30
Trial Details
NCT Number NCT06358859
Lead Sponsor Tufts University
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD), Tougaloo College, Mississippi, Delta Health Center, Mississippi, Reuben V. Anderson Center
Conditions Cardiometabolic Risk Factors, Diabetes, High Blood Pressure, Obesity, Nutrition Security
Enrollment 300 participants
Start Date 2024-06-05
Primary Completion 2027-05 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-04-14